News: IMC Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial..., page-10

My take on the situation. I see two scenarios.

1. Following the abysmal financials released last week the share price in both the US and locally has been in free fall. The market responded appropriately to the mismanagement of our funds. (Apologies if my tone offends) In an attempt to break the cycle a rushed preliminary announcement will be made full of fluff and fanfare, in an attempt to draw in more mum and dad investors (donors) to temporarily bolster the share price.

2. It has been deemed that the 1200mg is not well tolerated and or not statistically effective when compared to the placebo.


My reasoning, it was only a week or so ago we were informed that headline results would be published in June 24, why the sudden urgency?

Im hoping for scenario 1, as 2 would see the end of IMC and huge losses for all investors.